Sarah van Dijk

Sarah van Dijk is a dedicated Researcher in the Department of Neurology at Erasmus University Medical Center, specializing in neurofibromatosis type 1 (NF1) research. Her work spans clinical diagnostics, cognitive interventions, and quality-of-life assessments for NF1 patients.

Her primary research focuses on neurofibromatosis type 1, with significant contributions to understanding cognitive disorders, cutaneous neurofibromas, and symptomatic tumor management. Key areas include developing diagnostic ultrasound techniques, evaluating lamotrigine for cognitive deficits, and validating patient-reported outcome measures. Her fingerprint analysis reveals strong expertise in neurofibromatosis (100%), cognitive disorders (33%), and quality-of-life research (33%).

Recent publications demonstrate a clear trend toward translational clinical research, combining neurological examination techniques with patient-centered outcomes. Her work bridges neurology, endocrinology, and dermatology to address multisystem NF1 manifestations.

Collaborative work includes the ENCORE Expertise Center for NF1 and international research teams, with publications appearing in Clinical Neurophysiology, Developmental Medicine and Child Neurology, and Frontiers in Endocrinology.

Her research methodology emphasizes

• Prospective clinical studies
• Placebo-controlled trials
• Psychometric validation of instruments
• Multidisciplinary symptom analysis